Drug Type Small molecule drug |
Synonyms MR-3.15 |
Target |
Mechanism CK1 inhibitors(Casein kinase I inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC15H11ClN2OS |
InChIKeyBMKZSCWTKMUFTI-UHFFFAOYSA-N |
CAS Registry1579991-25-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Amyotrophic Lateral Sclerosis | Preclinical | ES | 27 Mar 2014 |